USANA Health Sciences Inc Total Liabilities
USANA Health Sciences Inc total liabilities. Based on the latest financial reports, USANA Health Sciences Inc (USNA) has total liabilities worth $144.18 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are USANA Health Sciences Inc's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of USANA Health Sciences Inc (1995–2025)
Total liabilities of USANA Health Sciences Inc from 1995 to 2025. This chart illustrates how USANA Health Sciences Inc's total liabilities have evolved over time, based on quarterly financial data.
USANA Health Sciences Inc Competitors by Total Liabilities
The table below lists competitors of USANA Health Sciences Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
NIIT LEARNING SYSTEMS LTD
NSE:NIITMTS
|
India | Rs-15.43 Billion |
|
T&L Co. Ltd
KQ:340570
|
Korea | ₩29.01 Billion |
|
Lionheart Holdings
NASDAQ:CUB
|
USA | $10.11 Million |
|
Youngtek Electronics
TWO:6261
|
Taiwan | NT$1.62 Billion |
|
Shenzhen Wongtee International Enterprise Co Ltd
SHE:000056
|
China | CN¥4.32 Billion |
|
INTERGRATED DIA.H DL 025
F:8I8
|
Germany | €3.22 Billion |
|
Information Services Group Inc
NASDAQ:III
|
USA | $108.77 Million |
|
Standard Biotools Inc
NASDAQ:LAB
|
USA | $87.25 Million |
Liability Composition Analysis (1995–2025)
This chart breaks down USANA Health Sciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see USNA current and non-current assets.
Liquidity & Leverage Metrics
USANA Health Sciences Inc Total Liabilities Ratios Explained
USANA Health Sciences Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.51 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how USANA Health Sciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for USANA Health Sciences Inc (1995–2025)
The table below shows the annual total liabilities of USANA Health Sciences Inc from 1995 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $156.64 Million | -3.22% |
| 2024-12-31 | $161.86 Million | +19.41% |
| 2023-12-31 | $135.56 Million | -16.36% |
| 2022-12-31 | $162.08 Million | -11.25% |
| 2021-12-31 | $182.62 Million | -8.34% |
| 2020-12-31 | $199.24 Million | +20.59% |
| 2019-12-31 | $165.22 Million | +1.17% |
| 2018-12-31 | $163.32 Million | +4.65% |
| 2017-12-31 | $156.06 Million | +7.36% |
| 2016-12-31 | $145.35 Million | +2.09% |
| 2015-12-31 | $142.38 Million | +18.24% |
| 2014-12-31 | $120.42 Million | +11.55% |
| 2013-12-31 | $107.95 Million | +31.99% |
| 2012-12-31 | $81.78 Million | +15.86% |
| 2011-12-31 | $70.59 Million | +20.38% |
| 2010-12-31 | $58.64 Million | +19.51% |
| 2009-12-31 | $49.06 Million | -45.93% |
| 2008-12-31 | $90.74 Million | +28.72% |
| 2007-12-31 | $70.49 Million | +77.09% |
| 2006-12-31 | $39.80 Million | +42.31% |
| 2005-12-31 | $27.97 Million | +17.42% |
| 2004-12-31 | $23.82 Million | +14.77% |
| 2003-12-31 | $20.76 Million | -1.26% |
| 2002-12-31 | $21.02 Million | +0.93% |
| 2001-12-31 | $20.83 Million | -7.92% |
| 2000-12-31 | $22.62 Million | -5.36% |
| 1999-12-31 | $23.90 Million | +154.26% |
| 1998-12-31 | $9.40 Million | +32.39% |
| 1997-12-31 | $7.10 Million | -18.39% |
| 1996-12-31 | $8.70 Million | +141.67% |
| 1995-12-31 | $3.60 Million | -- |
About USANA Health Sciences Inc
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Ess… Read more